Cargando…
Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats
The current available insulin therapies decrease blood glucose but are associated with the risk of developing hypoglycemia. Glucagon is a counter regulatory hormone and we hypothesize that a fixed ratio of insulin and a long‐acting glucagon‐analogue can reduce the risk of hypoglycemia. To define an...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875541/ https://www.ncbi.nlm.nih.gov/pubmed/29595915 http://dx.doi.org/10.14814/phy2.13657 |